2016 American Transplant Congress

Saturday, June 11, 2016

5:30pm-7:30pm

Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.

L. Rostaing,^1,2,3 A. Allal,¹ H. Naciri Benami,¹ Z. Abdulrahman,¹ L. Esposito,¹ F. Sallusto,¹ N. Doumerc,¹ X. Game,¹ B. Debiol,¹ N. Congy,¹ N. Kamar.^1,3,4

Poster Session A: Poster Session III: Kidney Complications-Other  •  Halls C&D

5:30pm-7:30pm

Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.

S. Kulkarni,¹ N. Kirkiles-Smith,² Y. Deng,³ R. Formica,⁴ M. Gilbert,⁵ V. Broeckner,⁶ L. Bow,¹ J. Pober.²

Poster Session A: Long Term Outcomes in Kidney Transplantation  •  Halls C&D

5:30pm-7:30pm

Effect of Isolated Intraperitoneal Sirolimus Treatment on the Kidneys of C57BL/6 Mice.

B. Kim,^1,3 Y. Cho,³ H. Lee,³ D. Joo,^2,3 K. Huh,^2,3 M. Kim,^2,3 Y. Kim.^2,3

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression  •  Halls C&D

5:30pm-7:30pm

Effect of Pylorus Preservation Procedure on Patient and Graft Outcome in Total Pancreatectomy with Islet Autotransplantation.

R. Shahbazov,¹ A. Dabous,² G. Yoshimatsu,² H. Fernandez,² G. Saracino,² B. Naziruddin,² N. Onaca,² P. Kim,² M. Levy.³

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics  •  Halls C&D

5:30pm-7:30pm

Effect on Endothelial function when Hyperglycemia Is Reversed by Single Pancreas Transplantation.

T. Halden,^1,2 I. Eide,^1,2 D. Dahle,¹ A. Åsberg,^1,3 A. Reisæter,¹ T. Jenssen,^1,4 A. Hartmann.^1,2

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics  •  Halls C&D

5:30pm-7:30pm

Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.

T. Sandow,¹ D. DeVun,¹ P. Gulotta,¹ H. Bohorquez,² D. Kirsch.¹

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Halls C&D

5:30pm-7:30pm

Eliminating Xenoantigen Expression on Swine Red Blood Cells.

Z.-Y. Wang,¹ G. Martens,¹ R. Blankenship,¹ R. Sidner,¹ P. Li,¹ J. Estrada,¹ M. Tector,² A. Tector.^1,3

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression  •  Halls C&D

5:30pm-7:30pm

Enabled PRA and Precision PRA: Alternatives to cPRA as Desensitization Trial Endpoints.

E. Woodle, M. Pando Rigal, S. Tremblay, A. Girnita.

Poster Session A: Kidney Desensitization  •  Halls C&D

5:30pm-7:30pm

End Stage Renal Disease Patients Have a Skewed T Cell Receptor Vbeta Repertoire.

L. Huang,¹ A. Langerak,² I. Wolvers - Tettero,² R. Meijers,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹

Poster Session A: Kidney: Acute Cellular Rejection  •  Halls C&D

5:30pm-7:30pm

End-Stage Renal Disease Does Not Impair the Large-Scale Generation of Potent Alloantigen-Specific Regulatory T Cells for Immunotherapy.

N. Litjens, K. Boer, J. Zuijderwijk, M. Klepper, A. Peeters, W. Verschoor, R. Kraaijeveld, C. Baan, M. Betjes.

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression  •  Halls C&D